Filters
Other countries
Results: 1 to 10 of 10
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
DCHS1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Nonsyndromic Congenital Heart Disease Panel PreventionGenetics, part of Exact Sciences United States | 54 | 44 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Connective Tissue Disorders Panel PreventionGenetics, part of Exact Sciences United States | 166 | 101 |
|
Mitral valve prolapse 2 NGS Test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Mitral valve prolapse 2 Deletion / Duplication Test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Mitral valve prolapse 2 Comprehensive Test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Mitral valve prolapse, myxomatous: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Results: 1 to 10 of 10
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.